MSME (Udyam registered) Ministry of MSME
- Category
- Small (2023-24)
- Udyam number
- UDYAM-HP-10-0000634
Astrazen Pharmaceuticals Private Limited
Astrazen Pharmaceuticals Private Limited - pharma in Panchkula, Haryana, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹4.5 Cr
▲ 4% YoY
Net loss · FY 2025
₹29.41 Lakh
Net margin -6.5%
EBITDA · FY 2025
₹10.53 Lakh
EBITDA margin 2.3%
Authorised capital
₹25 Lakh
Registered with MCA
Paid-up capital
₹10 Lakh
Issued & subscribed
Open charges
₹1.25 Cr
Secured borrowings
Company age
6 yrs
Est. 2020
Directors on board
3
As per MCA filings
About Astrazen Pharmaceuticals Private Limited
Data last updated:
Astrazen Pharmaceuticals Private Limited is a private limited company based in Panchkula, Haryana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 13 October 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Haryana, under CIN U24290HR2020PTC090053. Its GSTIN is 02AAUCA2011Q1ZM (Himachal Pradesh).
The company has an authorised share capital of ₹25 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors including Shailja Tiwari and Paras Nath Tiwary.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Sector 12, Panchkula, Haryana.
As per the financials filed for FY 2025, the company reported a revenue of ₹4.5 Cr, a growth of 4% compared to the previous year. For the same year it recorded a net loss of ₹29.41 Lakh (net margin -6.5%) and EBITDA of ₹10.53 Lakh (EBITDA margin 2.3%). Revenue has grown at a compounded annual rate (CAGR) of 170% over three years.
As per MCA filings, the company has open charges of ₹1.25 Cr on record. Court records list 5 cases involving the company, including 4 filed by the company and 1 filed against it; 5 cases are pending.
Astrazen Pharmaceuticals Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-HP-10-0000634). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U24290HR2020PTC090053
Registration Number 090053
Incorporation Date 13 October 2020
ROC Haryana
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-HP-10-0000634
Recognitions & Rankings of Astrazen Pharmaceuticals
Contact details
Astrazen Pharmaceuticals Private Limited's registered office is in Panchkula, Haryana. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressHouse 547, Sector 12A, Panchkula, Haryana, India – 134113
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Astrazen Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Astrazen Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Astrazen Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Astrazen Pharmaceuticals Private Limited, buy the company report.
Financials of Astrazen Pharmaceuticals Private Limited
FY 2025 filings availableAstrazen Pharmaceuticals Private Limited reported revenue of ₹4.5 Cr (up 4% YoY) for FY 2025.
Revenue · FY 2025
₹4.5 Cr ▲ 4%
Net loss · FY 2025
₹29.41 Lakh margin -6.5%
EBITDA · FY 2025
₹10.53 Lakh margin 2.3%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 4%
3 years · compounded
▲ 170%
EBITDA CAGR growth
1 year
▼ 82%
3 years · compounded
▲ 4%
Revenue has grown at a compounded annual rate (CAGR) of 170% over three years, including 4% growth in the latest year. EBITDA fell 82% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹10.53 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹29.41 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.3% | ||||
| Net Profit Margin | -6.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Astrazen Pharmaceuticals Private Limited, buy the company report.
Board of directors of Astrazen Pharmaceuticals Private Limited
Astrazen Pharmaceuticals has 3 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shailja Tiwari Also directs: Excipients Zone Limited | Director | 14 Mar 2023 | 3 Years 7 Months | Current |
| Paras Nath Tiwary Also directs: Excipients Zone Limited | Director | 16 Dec 2022 | 3 Years 10 Months | Current |
| Nirmal Kumar Nirala | Director | 27 Dec 2023 | 2 Years 10 Months | Current |
Peer comparison
Astrazen Pharmaceuticals Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Denizen Pharmaceuticals India Private Limited | ₹4.51 Cr (FY 2025) | 125.0% | New Delhi, Delhi, India | |||
| S N D Life Science Private Limited | ₹4.5 Cr (FY 2024) | 98.0% | Navi Mumbai, Maharashtra, India | |||
| Astrazen Pharmaceuticals Private Limitedthis company | ₹4.5 Cr (FY 2025) | -₹29.41 Lakh | -6.5% | 4.0% | Panchkula, Haryana, India | |
| S P M Drugs Private Limited | ₹4.49 Cr (FY 2025) | -30.0% | Erode, Tamil Nadu, India | |||
| Nice Pharmaceuticals Private Limited | ₹4.49 Cr (FY 2025) | 5.0% | Delhi, India | |||
| V C Pharmaceuticals (India) Private Limited | ₹4.48 Cr (FY 2025) | 1.0% | Paravur, Kerala, India |
To see the full peer comparison of Astrazen Pharmaceuticals Private Limited, buy the company report.
Auditor
Astrazen Pharmaceuticals Private Limited is audited by MEHAK OBEROI & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| MEHAK OBEROI & ASSOCIATES | FY 2023 | 039369N |
Shareholding
The shareholding of Astrazen Pharmaceuticals Private Limited is on record for 3 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Astrazen Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹1.25 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 21 Apr 2021 | 100457498 | Canara Bank | ₹1.25 Cr | Open |
To see the full charge records of Astrazen Pharmaceuticals Private Limited, buy the company report.
Total charge records: 1 View all charges
Legal cases
Astrazen Pharmaceuticals Private Limited has 5 court cases on record: 4 filed by Astrazen Pharmaceuticals, 1 filed against it. All cases are pending.
Total cases
5
Filed by the company
4
Filed against the company
1
Pending
5
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 5 | 1 | 5 |
Cases on record (4 of 5)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Sirmaur, Himachal Pradesh | Execution petition | Filed against the company by M/S Dynamic Enterprises | Pending |
| District court, Panchkula, Haryana | Cheque dishonour complaint | Filed by the company against M/S Nivia Life Science | Pending |
| District court, Panchkula, Haryana | Cheque dishonour complaint | Filed by the company against M/S Nivia Life Science | Pending |
| District court, Panchkula, Haryana | Cheque dishonour complaint | Filed by the company against M/S Nivia Life Science | Pending |
To see the full case history of Astrazen Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Astrazen Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Astrazen Pharmaceuticals Private Limited has 1 active EPFO establishment as of Mar 22, 2024.
Active EPFO establishments
1
GST
Astrazen Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 02AAUCA2011Q1ZM | Himachal Pradesh | Active | 20 Jan 2021 |
To see the full GST registrations and return filing status of Astrazen Pharmaceuticals Private Limited, buy the company report.
Recent activity
Astrazen Pharmaceuticals Private Limited has 8 board changes on record since 2022: 3 appointments and 5 cessations. The latest: Nirmal Kumar Nirala ceased to be Additional Director on 29 Sep 2024.
AGM
Astrazen Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Astrazen Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Haryana.
Ceased
Nirmal Kumar Nirala ceased to be Additional Director.
Appointed
Nirmal Kumar Nirala was appointed as Director.
Ceased
Paras Nath Tiwary ceased to be Additional Director.
Ceased
Shailja Tiwari ceased to be Additional Director.
Charges
A charge with Canara Bank of Rs. 125.00 Lakh registered on 21 Apr 2021 with Charge ID 100457498 was modified on 05 May 2023.
Appointed
Shailja Tiwari was appointed as Director.
Ceased
Susheel Kumar Jain ceased to be Director.
Ceased
Neha Bhatia ceased to be Director.
Appointed
Paras Nath Tiwary was appointed as Director.
Charges
A charge with Canara Bank amounted to Rs. 125.00 Lakh with Charge ID 100457498 was registered on 21 Apr 2021.
1 earlier event is in the company report.
Frequently asked questions
Astrazen Pharmaceuticals is an active private limited company based in Panchkula, Haryana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 13 October 2020 (6+ years old) and is registered under CIN U24290HR2020PTC090053.
Astrazen Pharmaceuticals has 3 current directors:
- Shailja Tiwari - Director
- Paras Nath Tiwary - Director
- Nirmal Kumar Nirala - Director
The latest financial statements of Astrazen Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Astrazen Pharmaceuticals is 02AAUCA2011Q1ZM, registered in Himachal Pradesh.
The CIN (Corporate Identification Number) of Astrazen Pharmaceuticals is U24290HR2020PTC090053. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Astrazen Pharmaceuticals has 5 court cases on record: 4 filed by the company and 1 filed against it. 5 are pending.
Astrazen Pharmaceuticals was incorporated on 13 October 2020, making it 6+ years old. It is registered with the Registrar of Companies, Haryana.
The peers of Astrazen Pharmaceuticals by revenue are Denizen Pharmaceuticals India Private Limited, S N D Life Science Private Limited, S P M Drugs Private Limited, Nice Pharmaceuticals Private Limited, V C Pharmaceuticals (India) Private Limited, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Nirmal Kumar Nirala ceased to be Additional Director on 29 Sep 2024. Nirmal Kumar Nirala was appointed as Director on 27 Dec 2023. Paras Nath Tiwary ceased to be Additional Director on 29 Sep 2023. Astrazen Pharmaceuticals has 8 board changes on record in total.
Yes, Astrazen Pharmaceuticals is registered as a small enterprise under Udyam registration (number: UDYAM-HP-10-0000634).
The registered office of Astrazen Pharmaceuticals is at House 547, Sector 12A, Panchkula, Haryana, India – 134113.